According to the latest SEC Filings, institutions owning shares of Bristol-Myers Squibb Company (NYSE:BMY) have decreased their positions by -5.40%. Institutions now own 70.10% of the company. Big organizations …
Technical Stock Analysis Shares outstanding are recorded as ... orphan diseases and negotiated the grant of an exclusive option to acquire Promedior to Bristol-Myers Squibb Company in 2015. On 24 February 2017, …
Bank of America
The stock is up 34% over the past 12 months ... 5.3% as the solar-panel maker reported that it swung to a loss on restructuring charges. Shares of Bristol-Myers Squibb Co.(BMY) rose 1.7% after news late Tuesday that …
Fidelity Investments
As the world's third-richest person and most celebrated investor, Warren Buffett attracts a lot of attention. Thousands track his investments and try to glean what they can from his thinking processes. In his most …
Shares of Bristol-Myers Squibb Co. (ticker: BMY) fell more than 16 percent Friday after the company announced that its Opdivo drug failed a study that would have expanded its use to lung cancer patients. BMY stock
Bristol-Myers Squibb Co. (NYSE: BMY ... On Thursday DryShips said that it will launch a 1-for-8 reverse stock split of common shares on January 23. At the time of the announcement DryShips had about 69.4 million …
Wall Street
The stock of Bristol-Myers Squibb Co (NYSE:BMY) hit a new 52-week low and has $46.32 target or 6.00% …
Market Gain and market value per Share Bristol-Myers Squibb Company(NYSE:BMY) has a Market Cap of 92289.33 that indicates the corporation’s current total value in the stock market which gives a comprehensive …
The data came from a detailed analysis of the Checkmate-26 study, whose main findings were released in August, causing Bristol-Myersstock to slump. Opdivo is part of a group of cutting-edge drugs that use …
Bristol-Myers Squibb